Categories
- Website Access and Utilization Related Questions
- ILPMP Related Questions
- Pharmacy or Dispensing Prescribers Reporting Related Questions
- Authorized User Designee Related Questions
- IL PMPnow Related Questions
- Opioid Treatment Programs (OTP) Related Questions
- Authorized Data Requests
- Peer Review Committee
- Website Early Access
Website Access and Utilization Related Questions
I don't remember if I have an account with ILPMP, is there any way to check?
Please visit our Forgot Username and enter your details. If you already have an account, your username will be sent to you via email.
I forgot my username, what should I do?
Please click on the Forgot Username to recover your username. After entering your information, an email will be sent to your email address on file with your Username.
How do I reset my password?
Please click on Forgot Password to reset your password. After entering your information, you will receive a temporary password (good for the calendar day it was requested) that can be used to login into your account. Once the temporary is entered, you will be asked to enter a new password.
I need my account re-activated due to non-usage. How do I procced?
Please visit our Contact Us page.
How do I update my ILPMP user account (new license number, new last name, e-mail address change, etc.)?
Log into the ILPMP.org website, click on your Username in the upper righthand corner and choose 'Update Profile'. You can update your address, licenses and other information there.
Who must register on the ILPMP website?
Each prescriber possessing an Illinois Controlled Substance License shall register with the ILPMP at the ILPMP website. Each prescriber or their designee shall also document an attempt to access patient information in the ILPMP to assess patient access to controlled substances when providing an initial prescription for Schedule II narcotics such as opioids, except for oncology treatment, palliative care, or for a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition. This attempt to access shall be documented in the patient's medical record. [705 ILCS 570/314.5(c-5)]
See Illinois General Assembly - Full Text of Public Act 100-0564
See Rule 2080.205 Accessing the ILPMP
Does utilizing the ILPMP through an Electronic Health Record integrated connection mean that you are registered?
No, every prescriber must register via ILPMP.org to be compliant with Public Act 100-0564.
Is there a penalty for failure to comply with the registration mandate?
The Department of Financial and Professional Regulation (IDFPR) is authorized to take disciplinary action against any prescriber for failure to comply with the registration mandate. Instances of non-compliance will be handled on a case-by-case basis.
What is considered "document the attempt to check the ILPMP"?
It will be up to the prescribers and the health care organizations to develop internal policies to ensure compliance with the documentation portion set forth in Public Act 100-0564.
Are there exemptions for checking the ILPMP?
See Illinois General Assembly - Full Text of Public Act 100-0564
ILPMP Related Questions
Who can access the data contained in the ILPMP?
Prescribers, dispensers, and their authorized designees may utilize the ILPMP for patient care after obtaining access authorization from the ILPMP staff.
Each prescriber or their designee shall also document an attempt to access patient information in the ILPMP to assess patient access to controlled substances when providing an initial prescription for Schedule II narcotics such as opioids, except for oncology treatment, palliative care, or for a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition. This attempt to access shall be documented in the patient's medical record. [705 ILCS 570/314.5(c-5)]
Can law enforcement officers have access to the ILPMP?
Law enforcement officers can have indirect access to the ILPMP data on a case-by-case basis. The request for ILPMP data must be accompanied by proper identification and the required legal documentation, such as a valid court order or subpoena, or an administrative subpoena issued by the Department of Financial and Professional Regulation, as mandated by HB5373.
Submission by Mail: Requests, along with supporting documents, should be mailed directly to the ILPMP at the following address:
Illinois Prescription Monitoring Program
401 N. 4th Street
Springfield, IL 62702
What prescriptions are required to be reported to the ILPMP?
The ILPMP is an electronic database that collects, tracks, and stores reported dispensing prescription data on Schedule II-V controlled substances, selected drugs of interest, and patient consented Opioid Treatment Program data. Prescriptions that are required to be reported to the ILPMP
- All Schedule II-V prescriptions (12-month history of all CII-V prescriptions dispensed in an Illinois retail pharmacy)
- Additional drugs of interest prescriptions that are mandated to be reported (12-month history of: Naltrexone, Naloxone, Butalbital/Acetaminophen/Caffeine, Muscle relaxants, Gabapentin)
- Opioid Treatment Program data may be reported only when patient consent is obtained from a provider in direct care of the patient.
How often is the data in the ILPMP updated?
Each time a Schedule II-V drug or other selected drugs, as described in Section 2080.230, is dispensed, the dispenser must transmit, by the end of the business day. The scripts are then collected and updated on the website each business day.
Why can't I find prescriptions that I know have been written and/or filled?
There could be several reasons for this:
- There may be a difference in patient's name spellings from how you think it is spelled and how it is actually listed in the PMP. For example, a prescription could have been written by a prescriber for a patient with the first name of "Jennifer" but the pharmacy filled it as "Jenifer". Enter the first few characters of the name up to the point where ambiguity may begin. For example, enter "Jen" as the patient first name in this case.
- A dispenser did not report the prescription on time.
- The dispensing pharmacy is not properly reporting their prescription data to us. If you think that is the situation, please let us know so we can contact that particular pharmacy.
As a prescriber, why do I see prescriptions in the ILPMP attributed to my DEA number that I did not prescribe and what can I do about it?
The dispensing pharmacy may have erroneously entered into their computer system your name/DEA number as the prescribing physician. Also,there is the possibility that unauthorized prescriptions are being written using your name and DEA number. Regardless, Contact Us and provide the ILPMP with the details of the discrepancy so we can determine the circumstances of the situation. We will keep you informed about what we find.
Can I consult with other prescribers and dispensers listed on the ILPMP without patient authorization?
According to the Health Insurance Portability and Accountability Act (HIPAA), this type of consultation is permitted because consultation is within the HIPAA definition of "treatment". For more information about HIPAA go to the United States Department of Health and Human Services Office for Civil Rights - HIPPA HOME | HHS.gov
How does the Health Insurance Portability and Accountability Act (HIPAA) effect the ILPMP?
Because the disclosures of information to the ILPMP by pharmacies are mandated and not discretionary, the patient does not need to be informed of the disclosure and does not need to consent to it. The ILPMP is not a HIPAA-covered entity, nor is it a business associate as defined by HIPAA, and therefore the requirements and standards for maintaining the security of the Protected Health Information-or for its redisclosure-that apply to HIPAA covered entities do not apply to the ILPMP. For more information about HIPAA go to the United States Department of Health and Human Services Office for Civil Rights - HIPPA HOME | HHS.gov
How can the ILPMP information help me in my daily practice of medicine?
The ILPMP is a clinical support tool used to help ensure safety in prescribing and dispensing of controlled substances and drugs of interest. Utilizing the ILPMP, healthcare providers can view 12 months of a patient's prescription history to aid in clinical decision-making for best patient outcomes. Licensed prescribers, authorized designees, and dispensers of controlled substances can view the ILPMP data for current and prospective patients only.
Is there any way for a large provider (i.e. hospital) to check in "a batch way" to see if their employees have registered?
Healthcare entities that are integrated through their Electronic Health Record system, Electronic Medical Record system or Pharmacy Management Systems are required to submit a list of their prescribers and pharmacists on a semi-annual basis. The IL PMPnow team will return a list to the healthcare entity including those prescribers or pharmacists that do not already have registered accounts. The healthcare entity can utilize this list to check prescriber registration and contact the prescribers who still need to register.
If an inpatient is being ordered a new controlled substance for in hospital use, does the prescriber (or their designees) have to look at the ILPMP first, before prescribing and dispensing?
No, the prescriber or dispenser is not required to look at the ILPMP in an inpatient setting, but please see Illinois General Assembly - Full Text of
Public Act 100-0564 for further information. The following section is taken from Publica Act 100-0564:
(f) This Section shall not be construed to apply to inpatients, residents at hospitals or other institutions, or to institutional pharmacies
How do I learn more about ILPMP?
More information can be found on ILPMP.org. For your convenience, ILPMP educational videos are linked below.
ILPMP Overview
Registering for an ILPMP account
ILPMP Pharmacy Reporting
PMPnow Integration
ILPMP Data Dashboards
ILPMP Educational Resources
ILPMP OTP Reporting
ILPMP Inter State Data Sharing and Integration
How do I subscribe to the ILPMP monthly newsletter?
Click Contact Us and provide a simple statement, like "Please add my e-mail address to the ILPMP Newsletter contact list."
Can out of state Medical Residents/Fellows register for an ILPMP account?
Medical Residents/Fellows that hold an Illinois Controlled Substance license and/or a DEA number may register for an ILPMP account. If you do not hold the required Illinois credentials, you will not be granted access to ILPMP.
Can Illinois Medical Residents register for an ILPMP account?
As a medical resident prescribing controlled substances in Illinois, your participation to utilize the ILPMP is required by law.
Please register for a free account by visiting www.ilpmp.org. Click Register, select ILPMP Website Registration, then choose the role Prescriber/ Resident.
• Residents must enter their Temporary Physician License number (pre-fix 125)
• Residents registering without individual DEA number, should use the hospital DEA number along with the 4 -digit post-fix.
• Residents are not required to enter an Illinois Controlled Substance License number and may leave that field blank.
See Medical Resident Registration Guidance link on registration page.
Pharmacy or Dispensing Prescribers Reporting Related Questions
How often do pharmacies or dispensing prescribers have to report prescription dispensing data to the ILPMP?
Each time a Schedule II-V drug or other selected drugs, as described in Section 2080.230, is dispensed, the dispenser must report electronically, by the end of the business day. See Rule 2080.100 Dispenser Responsibility
How do prescribers or dispensers report prescription errors?
See Rule 2080.220 Error Reporting
- If a prescriber notices an error in their prescription information, they shall report it to the dispensing pharmacy within 7 days after discovery of the error.
- A dispenser who notices an error in a prescription they have dispensed and transmitted shall retract the incorrect prescription and retransmit the prescription correctly within 7 days after discovery of the error.
As a dispenser who has nothing to report for the day, where do I find information on zero reporting?
See Rule 2080.100 Dispenser Responsibility
"If no Schedule II-V drug or other selected drug, as described in Section 2080.230, are dispensed, the dispenser must transmit a zero report, as outlined in the American Society of Automation in Pharmacy (ASAP) Prescription Monitoring Program Standard Version 4.2 (2011), to the central repository, no later than the end of the business day. The incorporation by reference includes no later amendments or editions."
Are there exemptions for reporting to the ILPMP?
The following are exemptions to reporting to the ILPMP:
- Dispenser is a medical facility that dispenses an interim quantity of a substance on an outpatient emergency basis.
- Quantity does not exceed a 72-hour supply.
- Pharmacy or Prescriber does not dispense ANY controlled substances II, III, IV and V or drugs of interest in the state of Illinois. Waiver can be accessed at RxSubmit Application (logicoy.com)
Authorized User Designee Related Questions
What is an authorized website designee?
An authorized licensed or non-licensed employee of a prescriber's office or pharmacy who has received training in the federal Health Insurance
Portability and Accountability Act (HIPAA) and 42 CFR Part 2. Authorized employee types include: registered nurse, licensed practical nurse,
pharmacy technician, student pharmacists, certified medical assistant, dental hygienist, and dental assistant.
See Rule 2080.205 Accessing the ILPMP
How many authorized designees may a prescriber's office or pharmacy have?
The prescriber or dispenser shall only have up to five website designees.
See Rule 2080.205 Accessing the ILPMP
How does a prescriber or pharmacy authorize a designee?
First, both prescriber or pharmacist and designee need to have an ILPMP user account. A prescriber or pharmacist can designate access to an authorized designee by using their State of Illinois License number. The prescriber or pharmacy will then be able to add linked accounts, remove, and monitor designee history while logged in to their account. Please note, authorized designees will have their own username and password as sharing of information is prohibited.
How often do supervising prescribers and pharmacists need verify designees?
Every 180 days the supervisor will need to login to their ILPMP account to review and verify current designees.
How will the authorized designee confirm their account is active?
An email will be sent to confirm the linking of the user accounts and activation.
Where can I find detailed information regarding authorized designees?
More information is available in the:
ILPMP Designee Manual
77-2080 Administrative Rule for Illinois Prescription Monitoring Program
Are out of state designees authorized to access to ILPMP?
No, for verification and authorization purposes, the ILPMP is only authorized to grant access to designees who both reside in Illinois and are currently employed within the State of Illinois.
IL PMPnow Related Questions
What is IL PMPnow?
IL PMPnow is the name the ILPMP uses to define the direct one-to-one connection/integration from a facility's: Electronic Health Record System
(EHR); Electronic Medical Record System (EMR); ONC Certified Health IT Module; or Pharmacy Management System. The connection creates in-workflow access to the ILPMP data from a patient record.
Under the Controlled Substance Act (Public Act 103-0477), "It is the responsibility of any new, ceased, or unconnected healthcare facility and
its selected Electronic Health Records System or Pharmacy Management System to make contact with and ensure integration with the
Prescription Monitoring Program."
How secure is the connection?
The connection uses national security standards and travels over a secure https web connection. The request and response have end to end encryption and is locked down by facility username and IP address.
How long will this connection take to implement into the EHR/Pharmacy Management Systems?
The integration process timeline depends on many factors. The Healthcare Entity needs to enter into a Memorandum of Understanding with the ILPMP. The choice of Integration Vendor and ability of the Application Vendor (EHR, EMR, Pharmacy Management Software, etc.) also plays a role in the length of the process. The ILPMP team will assist the Healthcare Entity through the process.
What is the difference between an Application Vendor and an Integration Vendor?
"Application Vendor" refers to the EHR, Electronic Medical Record (EMR), Certified Health IT module in combination with an EHR or EMR, or
pharmacy management software that is an end user interface, being utilized by a healthcare entity, prescriber, or dispenser in the treatment of
a patient.
"Integration Vendor" means a vendor that provides connectivity between an end user interface, such as an EHR, Certified Health IT Module, or a
pharmacy management system and the ILPMP.
How does an application vendor or integration vendor start the connection to the IL PMPnow?
720 ILCS 570/220
Under the Illinois Controlled Substance Act, Section 220, EHR systems shall certify the identity of a third party that will provide access to the PMP
for the EHR system using all or part of a computer program or system that is federally certified Health IT Module for the EHR.
720 ILCS 570/316.1
Under the Illinois Controlled Substance Act, Section 316.1, Integration Vendors are required to complete a Data Sharing Agreement (DSA) with
the Department of Human Services Prescription Monitoring Program and additional documents required by the Department of Information
Technology.
What is the cost of the integration?
Any costs will come from the Healthcare Entity's choice of Integration and Application Vendors. To determine these costs, please reach out to
your Integration and Application Vendors to understand the cost model associated with the integration process.
There are no charges from the ILPMP.
What steps does my organization take to connect with the IL PMPnow?
Any new or existing connections making changes needs to attend an educational session to review connection requirements, understand
Integration Vendor options, and then complete a Memorandum of Understanding (MOU) with Department of Human Services Prescription
Monitoring Program prior to connecting with the IL PMPnow integration.
Organizations connecting to the IL PMPnow integration must complete and submit a facility and provider template to the IL PMPnow team.
Integration process can begin once all items are received and approved.
Who can use this connection/integration?
IL PMPnow can be used by registered ILPMP users and their authorized designees (depending on their application and integration vendors).
See 2080.205 Accessing the ILPMP
Clerical office staff are not allowed to use the connection
How long will the ILPMP data be viewable on my EHR/Pharmacy Management Software?
Most integrations produce a single use URL web link. Some integrations provide the ability to save the data as a PDF or other static methods of retention. This depends on the build and contractual agreements with your application and integration vendors.
Are there any exemptions to the requirement to integrate?
See Rule 2080.207 EHR Integration with the ILPMP
My Electronic Health Record/application vendor is connected through a link to the website, does this meet requirements?
No, an IL PMPnow connection has specific requirements for developing the integration with the ILPMP database.
Is there a fine be for not connecting?
See Rule 2080.207 EHR Integration with the ILPMP
Does the ILPMP currently allow integration with ePrescription Modules or Health IT Modules that serve as an integrated component of an EHR/Pharmacy Management Software system?
Yes, amendments to the Administrative Rule, effective June 2021 allow for the use of an ONC Certified Health IT Module that is an integrated component of an EHR/Pharmacy Management Software with an attestation statement signed by the Health Care Organization or Pharmacy stating they will be using the ONC Certified Health IT Module.
Our office doesn't ePrescribe, do we still need to connect?
Yes, Illinois law states it is the responsibility of any new, ceased, or unconnected facility and its EHR or Pharmacy Management System to make contact with and ensure integration with the ILPMP. Electronic Prescription law is separate from the above. Please review the e-prescription requirements for ILCS 570/311.6 to better understand the requirements.
What is a Certified Health IT Module?
Any service, component, or combination thereof that can meet the requirements of at least one certification criterion adopted under the Office of the National Coordinator for Health Information Technology (ONC). In order to be an integrated component of the EHR/EMR or Pharmacy Management Software, the Health IT Module needs to already have access to the data and cannot be a third-party pass through, thus maintaining the one-to-one secure link.
Does IL PMPnow connectivity allow for multi-state queries?
Yes, IL PMPnow connectivity allows for interstate data searches with approved states.
Where can I find the Joint Committee on Administrative Rules: Administrative Code section on the EHR integration with ILPMP?
See Rule 2080.207 EHR Integration with the ILPMP
Does accessing the IL PMPnow integration/button make my ILPMP account active?
No, an account remains active if the provider accesses their account a minimum of once per year via ILPMP.org. This login is used to verify the providers demographic and license information.
Do we need to update the IL PMP on new providers/locations and exiting providers/locations?
Yes, see Rule 2080.207 EHR Integration with the ILPMP section D) 3) where an updated facility and provider template must be submitted semi-annually to the ILPMP. If your organization has a reporting plan, you can incorporate this semi-annual update into current workflows.
This update should include providers or dispensers who should be removed and added to the organization's connection.
My organization has multiple facilities, can I submit one file for all providers?
Yes, you can submit one file for all providers, but you should note which facility they are associated with. Depending on the development of the connection, all providers who are associated to your organization will be approved for all locations within that organization.
What if my organization buys or sells a healthcare facility or pharmacy?
If your organization acquires or sells a healthcare facility or pharmacy, the organization or appropriate party should contact the IL PMPnow team to determine next steps, which would include but not limited to the set-up call, MOU and updated facility and provider templates.
Are there any application vendor exemptions for the IL PMPnow connection?
Workplace health-focused systems are exempt from connecting. All other EHR and Pharmacy Management Systems must connect.
If my organization has a location in Illinois while my organizations' headquarters is located in another state are the providers/prescribers at the Illinois location required to have an active Illinois controlled substance license?
Yes, the providers/prescribers practicing in the State of Illinois must have an existing active controlled substance license if prescribing controlled substances within the borders of Illinois.
I should be able to access the IL PMPnow integration, but the button does not appear in my EHR software. Why is that?
You may need to contact your internal IT team or your application vendor to ensure you have been granted access.
Will I be able to e-prescribe if I am not connected to the IL PMPnow? Am I experiencing [issues/the inability to] e-prescribe because I am not connected to the IL PMPnow?
If you are not able to e-prescribe, you must contact your EHR. The IL PMPnow integration and ILPMP does not oversee or stop e-prescribing, this would be an internal or vendor issue.
Who/What is LogiCoy?
LogiCoy is a technical partner of the ILPMP who assist the IL PMPnow team in activating and maintaining the registration. The ILPMP data is not stored by LogiCoy, they are a support team for our program.
Why can't I see OTP patient data through my EHR, EMR, or Pharmacy Management system?
OTP data, from patients that consent to sharing data and their providers attest they are in direct care of the patient, may be available to providers who utilize an Integration Vendor and/or Application Vendor (EHR, EMR, or Pharmacy Management System) that supports the IL PMPnow interactive user interface. If the information is currently not available within your Application Vendor software, all direct care providers can view and access OTP data via our website at www.ILPMP.org.
Opioid Treatment Programs (OTP) Related Questions
I'm a provider, how will I know when a patient has OTP data to view on the patient profile?
If a patient is enrolled into an OTP an OTP icon will appear in the display. As you click on the OTP Data icon a pop up will appear stating "This patient is enrolled in an Opioid Treatment Program (OTP). ?Information contained in the OTP data icon has additional privacy and confidentiality protections under Federal Regulation 42 CFR Part 2. ?Please click 'I agree' to verify that you are involved in the direct care of this patient."
How often is OTP updated?
OTP data is updated every Thursday. Because of this, we highly recommend clicking the facility link provided on the patient's profile to call and verify the medication dosage.
Why can't I see OTP patient data through my EHR, EMR, or Pharmacy Management system?
OTP data, from patients that consent to sharing data and their providers attest they are in direct care of the patient, may be available to providers who utilize an Integration Vendor and/or Application Vendor (EHR, EMR, or Pharmacy Management System) that supports the IL PMPnow interactive user interface. If the information is currently not available within your Application Vendor software, all direct care providers can view and access OTP data via our website at www.ILPMP.org.
How will OTP data be stored within the ILPMP?
ILPMP complies to privacy and security measures set forth in 42 CFR Part 2.
See section 2.32 Prohibition on re-disclosure of eCFR :: 42 CFR Part 2 -- Confidentiality of Substance Use Disorder Patient Records
Can users print, save, or download OTP data?
OTP data cannot be printed, shared, screen captured (in any format) or saved under any circumstances. See section 2.32 Prohibition on re-disclosure of eCFR :: 42 CFR Part 2 -- Confidentiality of Substance Use Disorder Patient Records
What is the difference between HIPAA and 42 CFR Part 2?
HIPAA protects the privacy and security of general health information and applies to covered entities (healthcare providers, health plans,
healthcare clearinghouses) and business associates. The purpose of HIPAA is to protect health data integrity, confidentiality, and accessibility.
HIPAA permits disclosures without patient consent for treatment, payment, and healthcare operations. 42 CFR Part 2 protects the privacy and
security of records identifying individuals as seeking or receiving SUD treatment from a "Part 2 program." The purpose is to encourage people to
enter and remain in SUD treatment by guaranteeing confidentiality. The regulation requires patient consent for most disclosures, including for
treatment, payment, and healthcare operations, with limited exceptions.
For more information, refer to 42 CFR Part 2 and PDMPs: Frequently Asked Questions (pdmpassist.org)
For additional questions, please call the OTP facility.
Who do I contact for OTP related questions?
For questions regarding reporting requirements, patient consent form, patient brochure
contact: Richard Weisskopf at richard.weisskopf@illinois.gov
For technical issues with using the ILPMP contact us dhs.pmp@illinois.gov
For facility questions, please contact the OTP facility via the facility hyperlink on the patient's OTP profile
Authorized Data Requests
How does a patient request a Patient Information Report?
A personal information report of a patient's prescription profile may be obtained if:
- The patient, parent, or guardian completes a notarized request; and
- The patient, parent, or guardian submits the notarized request by mail to the ILPMP at:
The request shall contain the following criteria:
- State-issued photo I.D. of requestor containing:
- Name
- Date of Birth
- Address
- Notarized typed letter
- Personal Information
- Name
- Date of Birth
- Address
- Phone Number
- Information Requested (either/or both)
- Prescription History
- List of PMP users who have performed searches on the patient
- The date range of requested information
- Patient's Signature
The results of the patient query shall be provided to the requestor via certified postal mail to the address provided on the state-issued identification.
Is there a fee for requesting a Patient Information Report?
No
Who is considered an authorized data requestor?
(1) A governing body that licenses practitioners and is engaged in an investigation, an adjudication, or a
prosecution of a violation under any State or federal law that involves a controlled substance.
(2) An investigator for the Consumer Protection Division of the office of the Attorney General, a prosecuting
attorney, the Attorney General, a deputy Attorney General, or an investigator from the office of the Attorney
General, who is engaged in any of the following activities involving controlled substances: (A) an investigation;
(B) an adjudication; or (C) a prosecution of a violation under any State or federal law that involves a controlled
substance.
(3) A law enforcement officer who is: (A) authorized by the Illinois State Police or the office of a county sheriff
or State's Attorney or municipal police department of Illinois to receive information of the type requested for the
purpose of investigations involving controlled substances; or (B) approved by the Department to receive information
of the type requested for the purpose of investigations involving controlled substances; and (C) engaged in the
investigation or prosecution of a violation under any State or federal law that involves a controlled substance.
Why has the authorized data request process been revised?
Public Act 103-1064, effective February 7, 2025, has been incorporated into the Illinois Controlled Substance Act. This legislation introduces stricter requirements for obtaining confidential information from the Illinois Prescription Monitoring Program (ILPMP). For full details, refer to the General Assembly - Full Text of Public Act 103-1064.
Under Public Act 103-1064, applicants requesting information from the ILPMP must provide the following:
- Reason for Suspicion of a Violation
- The requester must have reason to believe that a violation involving a controlled substance has occurred under state or federal law.
- Demonstration of Relevance
- The requested information must be reasonably related to the investigation, adjudication, or prosecution of the suspected violation.
- If this justification cannot be established, patient information report may be required.
- Legal Documentation Requirements
- A valid court order or subpoena
- An administrative subpoena will only be accepted if issued by the Department of Financial and Professional Regulation (IDFPR)
- Department of Children and Family Services (DCFS) requests do not require a court order or subpoena. DCFS requestors may submit securely via an encrypted e-mail to: dhs.pmp@illinois.gov
What detailed information is needed on the administrative subpoena submitted by IDFPR?
An administrative subpoena must include all required identification and documentation for processing:
- Proper identification of the requestor including:
- Name
- Badge number, if applicable
- Office address
- Phone number
- Case number
- Administrative subpoena number, if applicable
- Signature
- Date range of the data requested
- Reason for request
- Type of request: Indicate the nature of the request by selecting one of the following:
- Patient Request: Must include patient's first and last name, date of birth, and any known name aliases.
- Prescriber or Dispenser Request: Must include the prescriber's or dispenser's name and DEA number.
How do I submit supporting documentation to receive the confidential data requested?
Fax or Mail request to ILPMP:
- Submission by Fax: Detailed legal documentation should be faxed directly to ILPMP at 217-557-7975
- Submission by Mail: Detailed legal documentation should be mailed directly to the ILPMP at the following address:
Illinois Prescription Monitoring Program
401 N. 4th Street
Springfield, IL 62702
What is the data transmission process?
Upon receipt of the required legal documentation, ILPMP staff will securely transmit the requested data via an encrypted e-mail in an Excel spreadsheet format.
Do authorized data requestors have to pay a fee?
No.
What detailed information is needed for a subpoena or court order?
A Subpoena or Court Order must include all required identification and documentation for processing:
- Proper identification of the requestor including:
- Name
- Badge number, if applicable
- Office address
- Phone number
- Case number
- Signature
- Date range of the data requested
- Reason for request
- Type of request: Indicate the nature of the request by selecting one of the following:
- Patient Request: Must include patient's first and last name, date of birth, and any known name aliases.
- Prescriber or Dispenser Request: Must include the prescriber's or dispenser's name and DEA number.
Peer Review Committee
What is the Peer Review Committee?
The Peer Review Committee is a subcommittee of the ILPMP Advisory Committee and is comprised of 10 members. Members
may identify prescribers or dispensers who may be prescribing or dispensing outside the currently accepted medical
standards of their professional practice and send the identified prescriber or dispenser a request for information
regarding their prescribing or dispensing practices. Meetings are held at least bi-annually.
This short video describes the role and composition of the peer review subcommittee of the ILPMP Advisory Committee.
Peer Review Committee
Why did the Peer Review Committee send me a Request For Information (RFI) letter?
Members of the Illinois Prescription Monitoring Program Peer Review Committee have been charged under 720 ILCS 570/320 to identify those prescribers who MAY be prescribing outside the currently accepted standards of practice for their profession. If you have received a RFI letter, please follow the directions to respond. The Committee will review your responses within 90 days. Please note that this letter is not meant to be punitive but to work together to aid in safe patient care and safety.
Website Early Access
What do I need to do to gain access to the new website?
Visit prod.ilpmp.org and log in using your current username and password. No additional registration is required for existing users.
How should I use the new website?
Users should perform searches as they normally do. The data is kept up to date with the current website.
I am a designee but am unable to perform searches on the new website, what is wrong?
Designees must ensure that their supervising provider has also transitioned to the new website.
A designee’s ability to conduct searches is dependent upon their supervisor’s migration.